维普期刊资源整合服务平台（V6.5）

122篇 您的检索式：作者名="Czuczman"

选中清除导出查看参考文献查看引证文献引用追踪共7页首页上一页第1页下一页末页 /7 跳转

	题名	作者	年代	出处	被引量
1	Acquirement of rituximab re- sistance in lymphoma cell lines is associated with both global CD20 gene and protein down - regulation regulated at the pretranscriptional and posttranscriptional Levels 显示文摘	Myron S Czuczman S Olejniczak AG	2008	Clin Cancer Res2008，14，5：	1
2	Navitoclax,a targeted high-affinity inhibitor of BCL-2,in lymphoid malignancies:A phase Ⅰ dose-escalation study of safety,pharmacokinetics,pharmacodynamics,and antitumour activity显示文摘	Wilson WH O'Connor OA Czuczman MS		0，，12：	1
3	Rituximab in combination with CHOP or fludarabine in low-grade lymphoma 显示文摘	Czuczman M S Fallon A Mohr A	2002	Semin Oncol2002，29，2：	1
4	Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti CD20 monoclonal antibody and CHOP chemotherapy显示文摘	Czuczman MS Grillo-Lopez AJ White CA	1999	J Clin Oncol1999，17，1：	1
5	Ofatumumab monotherapy in rituximab-refractory follicular lymphoma:results from a multicenter study显示文摘	Czuczman MS Fayad L Delwail V	2012	{H}Blood2012，，16：	1
6	Ofatumumab monotherapy in rituximab-refractory follicular lymphoma: results from a multicenter study显示文摘	Czuczman MS Fayad L Delwail V	2012	Blood2012，，：	1
7	Patients with low-grade NHL treated with rituximab + CHOP experience prolonged clinical and molecular remission显示文摘	CZUCZMAN M GRILLO-LOPEZ AJ LOBUGLIO AI	2003	Blood2003，102，：	1
8	Chemoimmunotherapy with ofatumumab in combination with CHOP in previously untreated follicular lymphoma显示文摘	Czuczman MS Hess G Gadeberg OV	2012	Br J Haematot2012，157，4：	1
9	Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric aiti-CD20 monoclonal antibody and C HOP chemotherapy 显示文摘	Czuczman MS Grillo AZ White CA	1999	J Clin Oncol1999，17，2：	1
10	Immunochemotherapy in indolent nonHodgkin'slymphoma显示文摘	CZUCZMAN MS	2002	Semin Oncol2002，29，26：	1
11	Treatment of patients with low-grade B cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy 显示文摘	Czuczman MS Grillo-Lopez AJ White CA	1999	J Clin Oncol1999，17，：	1
12	A phase 2/3multicenter, randomized study comparing the efficacy and safety oflenalidomide versus investigator's choice in relapsed/refractoryDLBCL 显示文摘	Czuczman MS Davies AJ Linton KM	2014	Proceedings of ASH2014，，：	1
13	Ofatumumab monotherapy in rituximab-refractory follicular lymphoma: results from a multicenter study显示文摘	Czuczman MS Fayad L Delwail V	2012	Blood2012，219，16：	1
14	Ofatumumab in combination with ICE or DHAP chemotherapy in relapsed or refractory intermediate grade B-cell lymphoma显示文摘	Matasar M J Czuczman MS Rodriguez MA	2013	Blood2013，122，4：	1
15	Ofatumumab in combination with ICE or DHAP chemotherapy in relapsed or refractory intermediate grade B-cell lymphoma显示文摘	Matasar MJ Czuczman MS Rodriguez MA	2013	Blood2013，122，4：	1
16	Value of immunopheno- type in intensively treated adult acute lymphoblastic leukemia:cancer and leukemia Group B study $364 显示文摘	Czuczman MS Dodge RK Stewart CC	1999	Blood1999，93，11：	1
17	Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric antiCD20 monoclonal antibody CHOP chaemotherapy显示文摘	Czuczman MS Grillo-Lopez AJ White CA	1999	J Clin Oncol1999，17，1：	1
18	Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma显示文摘	Dunleavy K Pittaluga S Czuczman M S	2009	Blood2009，113，24：	1
19	Ofatumumab monotherapy in rituximab-refractory follicular lymphoma:results from a multicenter study 显示文摘	Czuczman MS Fayad L Delwail V	2012	Blood2012，119，16：	1
20	Value of immunophenotyping in intensively treated adult acute lymphoblastic leukemia: cancer and leukemia group B study 8364 显示文摘	Czuczman M S Dodge R K Stewart C C	1999	Blood1999，93，11：	1

返回顶部每页显示：

共7页首页上一页第1页下一页末页 /7 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示